What is Grannus Therapeutics worth?
$5.0Mlast known valuation
Grannus Therapeutics last raised $800K in its Debt (Nov 2023).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Grannus Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2023 | Debt | $800K | ▮ | ▮ |
| Jan 2022 | Seed Round | $950K | ▮ | ▮ |
How Grannus Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Grannus Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Grannus Therapeutics worth?
- Grannus Therapeutics's last known valuation is $5.0M.
- How much has Grannus Therapeutics raised?
- Grannus Therapeutics has raised $2.9M in total funding across 2 recorded rounds.
- When did Grannus Therapeutics last raise?
- Grannus Therapeutics last raised in Nov 2023 (Debt), raising $800K.